WEIR monoclonal antibody contract

Forecast Overview

NAICS

541714

Performance end

5/2026

WEIR monoclonal antibody contract. Strain specific influenza monoclonal antibodies are needed for development alternative potency assays for pandemic influenza vaccines.

Source

Source

HHS SBCX Forecast Export

Source file

Forecast.csv

Official source

Agency forecast source

Last verified

2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Related Federal Entities

• Department of Health and Human Services · agency
• CARLSON DNA Sequencing · related forecast
• Off-site Poliovirus-related Samples Repository Services for CBER · related forecast
• Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (ChemDB) · related forecast
• Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases · related forecast
• Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases · related forecast
• Federal Technology Spending Map · spending map
• Federal Opportunity Research · resource